We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.09B
AUM Growth
+$15.8M
Cap. Flow
-$86M
Cap. Flow %
-4.12%
Top 10 Hldgs %
18.08%
Holding
266
New
20
Increased
45
Reduced
134
Closed
56

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18.8M
2
TENB icon
Tenable Holdings
TENB
+$16.8M
3
LIVN icon
LivaNova
LIVN
+$14M
4
FN icon
Fabrinet
FN
+$13.9M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
ACDC icon
ProFrac Holding
ACDC
+$26.1M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$21.4M
3
CUBI icon
Customers Bancorp
CUBI
+$16M
4
MTSI icon
MACOM Technology Solutions
MTSI
+$14.6M
5
PRFT
Perficient Inc
PRFT
+$13.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.06%
2 Technology 16.79%
3 Industrials 15.69%
4 Consumer Discretionary 14.06%
5 Financials 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHD icon
26
Cactus
WHD
$3.78B
$24.4M 1.17%
592,539
-100,278
-14% -$4.84M
MC icon
27
Moelis & Co
MC
$5.02B
$24.4M 1.17%
633,983
-100,709
-14% -$4.33M
GTLS icon
28
Chart Industries
GTLS
$23.8M 1.14%
189,866
-1,440
-0.8% -$185K
VRNS icon
29
Varonis Systems
VRNS
$5.46B
$23.7M 1.14%
912,921
-41,289
-4% -$1.08M
PLMR icon
30
Palomar
PLMR
$3.59B
$23.7M 1.14%
429,773
-105,561
-20% -$5.66M
CELH icon
31
Celsius Holdings
CELH
$7.41B
$23M 1.11%
743,790
+41,526
+6% +$1.31M
PRVA icon
32
Privia Health
PRVA
$3.39B
$22.8M 1.09%
826,044
-10,025
-1% -$265K
FWRD icon
33
Forward Air
FWRD
$435M
$22.4M 1.08%
208,235
-2,998
-1% -$315K
TNET icon
34
TriNet
TNET
$2.74B
$22.2M 1.06%
275,411
-106,042
-28% -$8.3M
PDFS icon
35
PDF Solutions
PDFS
$2.14B
$21.5M 1.03%
506,737
+115,572
+30% +$4.05M
ATRC icon
36
AtriCure
ATRC
$1.77B
$21.1M 1.01%
507,858
-9,259
-2% -$384K
MDGL icon
37
Madrigal Pharmaceuticals
MDGL
$12.8B
$19.9M 0.95%
82,064
+69,076
+532% +$18.8M
PPBI
38
DELISTED
Pacific Premier Bancorp
PPBI
$19.7M 0.95%
821,217
-24,882
-3% -$753K
ALKS icon
39
Alkermes
ALKS
$8.79B
$19.7M 0.95%
699,499
+60,069
+9% +$1.64M
BPMC
40
DELISTED
Blueprint Medicines
BPMC
$19.7M 0.95%
438,249
+47,093
+12% +$2.12M
RARE icon
41
Ultragenyx Pharmaceutical
RARE
$2.88B
$19.7M 0.94%
490,161
+145,436
+42% +$6.24M
COLL icon
42
Collegium Pharmaceutical
COLL
$1.17B
$19.3M 0.92%
803,136
-10,553
-1% -$280K
CHX
43
DELISTED
ChampionX
CHX
$18.6M 0.89%
687,257
+98,422
+17% +$2.94M
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$18.3M 0.88%
754,032
-6,012
-0.8% -$132K
SNCY
45
DELISTED
Sun Country Airlines
SNCY
$18.1M 0.87%
882,272
+162,594
+23% +$3.16M
MTDR icon
46
Matador Resources
MTDR
$6.68B
$18M 0.86%
378,028
-1,657
-0.4% -$93.2K
PTLO icon
47
Portillo's
PTLO
$338M
$18M 0.86%
842,910
-13,514
-2% -$284K
AVAV icon
48
AeroVironment
AVAV
$7.2B
$17.9M 0.86%
195,027
+19,504
+11% +$1.73M
UTHR icon
49
United Therapeutics
UTHR
$22.7B
$17.5M 0.84%
78,086
-16,356
-17% -$4.03M
BJRI icon
50
BJ's Restaurants
BJRI
$1.42B
$17.4M 0.83%
597,343
-11,202
-2% -$349K
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, Emerald Advisers held 266 positions worth $2.09B, up 0.76% from $2.07B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers withdrew a net $86M in Q1 2023, closing 56 positions and reducing 134 holdings. Its most notable exit was ProFrac Holding, an estimated $26.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Emerald Advisers opened a new position in LivaNova worth $12.1M.

  • Emerald Advisers's largest Q1 2023 buy was LivaNova: 277,388 shares worth $12.1M.
  • Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $18.8M increase.
  • Emerald Advisers's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $21.4M.
  • Emerald Advisers fully exited ProFrac Holding in Q1 2023, selling an estimated $26.1M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.09B portfolio in Q1 2023.
  • Emerald Advisers opened 20 new positions and closed 56 in Q1 2023.
  • Emerald Advisers's portfolio value rose 0.76% quarter-over-quarter to $2.09B.

Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.